Like Countable?

Install the App
TRY NOW

house Bill H.R. 3917

Medicare Nuclear Medicine Payment Group Clarification Act of 2009

bill Progress


  • Not enacted
    The President has not signed this bill
  • The senate has not voted
  • The house has not voted
      house Committees
      House Committee on Energy and Commerce
      Health
      House Committee on Ways and Means
    IntroducedOctober 22nd, 2009

Bill Details

Official information provided by the Congressional Research Service. Learn more or make a suggestion.
The Congressional Research Service writes summaries for most legislation. These summaries are listed here. Countable will update some legislation with a revised summary, title or other key elements.

Suggest an update to this bill using our form.

Title

Medicare Nuclear Medicine Payment Group Clarification Act of 2009

Official Title

To amend title XVIII of the Social Security Act to modernize and improve the Medicare payment methodology for radiopharmaceuticals under the hospital outpatient prospective payment system and to ensure equitable payment and patient access to certain low volume, high cost radiopharmaceuticals.

Summary

Medicare Nuclear Medicine Payment Group Clarification Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act to revise requirements for treatment of certain costs for a nuclear medicine group in the prospective payment system (PPS) for hospital outpatient department services. Declares that services classified within a nuclear medicine group shall not be treated as comparable with respect to the use of resources, and therefore shall be excluded from the group, if the highest median cost (or, at the Secretary's election, mean cost) of any associated diagnostic radiopharmaceutical included in the payment for the service within the group is more than two times greater than the lowest median cost (or mean cost, if so elected) for a service within the group.

    There are currently no opinions on this bill, be the first to add one!